Rishabh Chawla

Rishabh Chawla has a diverse background in biochemistry, molecular biology, and biotechnology. With experience in various roles at companies like Gimv, Complement Therapeutics, and Kinaset Therapeutics, Rishabh has been involved in identifying and evaluating innovative healthcare technologies, participating in board meetings, and liaising with key stakeholders. With a Ph.D. in Biochemistry and Molecular Biology, Rishabh has contributed to the formation and strategic planning of companies like Dualyx and Biodol.